BioLife Solutions (BLFS) PT Raised to $18 at Maxim Group as Cell Media Revs Beat Expecations
Maxim Group raised its price target on BioLife Solutions (NASDAQ: BLFS) to $18.00 (from $12.00) while maintaining a Buy rating.Analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
